Get 20% lifetime commission for referring investors to digrin.com
here.
Outlook Therapeutics, Inc. (OTLK) Financials
OTLK Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 26.2 million | ? |
| March 31, 2026 | 21.9 million | 50.9 million |
| Dec. 31, 2025 | 18.2 million | 56.8 million |
| Sept. 30, 2025 | 18.6 million | 50.8 million |
OTLK Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | ? | ? |
| March 31, 2026 | -7.8 million | 757484 |
| Dec. 31, 2025 | -14.9 million | 881150 |
| Sept. 30, 2025 | -12.4 million | 1.8 million |
OTLK Net Income
No data available :(
OTLK Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 11.2 million | - | - |
| March 31, 2026 | 7.7 million | 11.1 million | 218961 |
| Dec. 31, 2025 | 8.7 million | - | 233113 |
| Sept. 30, 2025 | 8.1 million | - | 247698 |
OTLK Shares Outstanding
OTLK Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | - | 3.3 million | 7.6 million | - |
| March 31, 2026 | - | 4.5 million | 9.5 million | - |
| Dec. 31, 2025 | - | 3.6 million | 8.6 million | - |
| Sept. 30, 2025 | - | 6.0 million | 10.3 million | - |
OTLK Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 9000 | 17000 |
| March 31, 2026 | 127439 | 149327 |
| Dec. 31, 2025 | -1.2 million | 29626 |
| Sept. 30, 2025 | -91787 | 916515 |
OTLK
Price: $0.70
52 week price:
Payout Ratio Range:
Earnings Per Share: -1.13 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 308347
Market Capitalization: 141.4 million